TELA Bio (TELA) EBIT Margin Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -361.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 102.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 241.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 851.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -313.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 535.00 |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn | 132.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 132.00 |
| Dec 31, 2025 | -13,262.00 |
| Sep 30, 2025 | 1,289.00 |
| Jun 30, 2025 | 2,694.00 |
| Mar 31, 2025 | -2,748.00 |
| Dec 31, 2024 | 17,300.00 |
| Sep 30, 2024 | 1,824.00 |
| Jun 30, 2024 | -41.00 |
| Mar 31, 2024 | 6,543.00 |
| Dec 31, 2023 | 898.00 |
| Sep 30, 2023 | 1,738.00 |
| Jun 30, 2023 | 2,688.00 |
| Mar 31, 2023 | 2,510.00 |
| Dec 31, 2022 | 1,019.00 |
| Sep 30, 2022 | 927.00 |
| Jun 30, 2022 | -164.00 |
| Mar 31, 2022 | 409.00 |
| Dec 31, 2021 | 2,766.00 |
| Sep 30, 2021 | 3,488.00 |
| Jun 30, 2021 | 5,057.00 |
| Mar 31, 2021 | 5,074.00 |
| Dec 31, 2020 | 72.00 |
| Sep 30, 2020 | -3,212.00 |
| Jun 30, 2020 | -1,712.00 |
| Mar 31, 2020 | -1,774.00 |
| Dec 31, 2019 | 10,676.00 |
| Sep 30, 2019 | 1,705.00 |